Current Value
$15.951 Year Return
Current Value
$15.951 Year Return
Double maintains 1 strategies that include IMVT - Immunovant, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 67.03% | $4.95B | 0.35% |
IBB | 62.82% | $5.36B | 0.45% |
GNOM | 58.53% | $44.43M | 0.5% |
BBH | 56.56% | $329.82M | 0.35% |
PBE | 56.34% | $223.24M | 0.58% |
FBT | 55.90% | $1.01B | 0.54% |
PINK | 55.02% | $133.06M | 0.5% |
XPH | 53.40% | $149.79M | 0.35% |
PTH | 51.26% | $101.07M | 0.6% |
ARKG | 50.63% | $1.05B | 0.75% |
IWO | 49.66% | $11.48B | 0.24% |
IWC | 48.95% | $824.65M | 0.6% |
KJUL | 48.74% | $120.75M | 0.79% |
FXH | 48.72% | $898.02M | 0.62% |
VTWO | 48.68% | $13.29B | 0.07% |
ISCG | 48.61% | $679.06M | 0.06% |
IWM | 48.53% | $64.00B | 0.19% |
QQQJ | 48.43% | $617.03M | 0.15% |
SCHA | 48.31% | $17.26B | 0.04% |
KJAN | 47.97% | $289.38M | 0.79% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ROIV | 62.19% | $7.74B | +7.76% | 0.00% |
DNLI | 54.64% | $2.05B | -39.28% | 0.00% |
OCUL | 54.17% | $1.47B | +34.80% | 0.00% |
CGON | 53.39% | $1.98B | -17.80% | 0.00% |
IDYA | 51.39% | $1.87B | -39.13% | 0.00% |
XENE | 51.37% | $2.49B | -16.90% | 0.00% |
RVMD | 50.84% | $6.88B | -4.90% | 0.00% |
CYTK | 49.45% | $3.96B | -38.80% | 0.00% |
ACLX | 49.29% | $3.60B | +18.41% | 0.00% |
IONS | 49.12% | $6.33B | -16.49% | 0.00% |
COGT | 49.07% | $808.38M | -15.78% | 0.00% |
KYMR | 49.02% | $2.87B | +47.81% | 0.00% |
CRNX | 48.84% | $2.81B | -33.11% | 0.00% |
CLDX | 48.77% | $1.35B | -45.18% | 0.00% |
IMNM | 48.56% | $763.10M | -27.52% | 0.00% |
KRYS | 47.11% | $4.01B | -24.37% | 0.00% |
RNA | 46.91% | $3.50B | -28.94% | 0.00% |
CRSP | 46.76% | $4.10B | -12.07% | 0.00% |
NRIX | 46.49% | $887.38M | -44.23% | 0.00% |
VSH | 46.33% | $2.16B | -28.43% | 2.50% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -39.04% | $165.69M | 0.85% |
TAIL | -37.16% | $99.76M | 0.59% |
BTAL | -32.02% | $296.79M | 1.43% |
ULST | -23.40% | $662.59M | 0.2% |
IVOL | -19.39% | $349.27M | 1.02% |
FTSD | -18.24% | $231.79M | 0.25% |
XONE | -13.69% | $585.86M | 0.03% |
FXY | -12.32% | $815.67M | 0.4% |
KCCA | -11.52% | $105.63M | 0.87% |
TFLO | -8.87% | $6.83B | 0.15% |
SCHO | -8.29% | $11.46B | 0.03% |
TPMN | -7.99% | $30.81M | 0.65% |
SPTS | -7.96% | $5.78B | 0.03% |
XHLF | -7.80% | $1.73B | 0.03% |
UTWO | -7.19% | $379.36M | 0.15% |
IBTH | -7.07% | $1.60B | 0.07% |
BUXX | -6.93% | $318.71M | 0.25% |
JMST | -6.77% | $4.06B | 0.18% |
BILS | -6.64% | $3.86B | 0.1356% |
CANE | -5.93% | $10.44M | 0.29% |
SeekingAlpha
Baker Brothersâ Q1 2025 portfolio reveals biotech investment trends. See more on their top holdings, stake changes, and high-conviction strategies.
SeekingAlpha
Immunovant: Navigating The Complexities Of The FcRn Landscape (Downgrade)
SeekingAlpha
Tourlite Fund, LP returned â4.6% for the First Quarter of 2025. Click here to read the full fund letter.
Yahoo
Immunovant stock rises on encouraging fourth-quarter fiscal 2025 results. It is on track to initiate 10 studies on IMVT-1402 across various autoimmune indications.
Finnhub
Immunovant, Inc. reported earnings results for the fourth quarter and full year ended March 31, 2025. For the fourth quarter, the company reported net loss was USD 106.45 million compared to USD 75.32...
Yahoo
Immunovant’s new management team is focused on rapid clinical execution for the six announced indications for IMVT-1402, including a second potentially registrational study in Graves’ disease (GD) and a potentially registrational study in Sjögren’s disease (SjD), both expected to start in summer 2025Positive data from first-generation batoclimab trials in myasthenia gravis (MG) and chronic inflammatory demyelinating polyneuropathy (CIDP) demonstrated that deeper IgG reductions correlated with im
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PRT | 0.01% | $51.58M | +9.00% | 10.33% |
SRRK | -0.02% | $3.40B | +329.89% | 0.00% |
MSEX | -0.07% | $976.83M | +4.31% | 2.48% |
BTI | 0.13% | $102.80B | +51.83% | 8.07% |
CREG | -0.27% | $5.81M | -77.49% | 0.00% |
COR | 0.34% | $58.03B | +32.90% | 0.72% |
GFI | -0.40% | $20.47B | +53.49% | 2.38% |
DFDV | -0.56% | $247.94M | +1,821.34% | 0.00% |
LTM | -0.65% | $12.12B | -95.54% | 2.48% |
ZCMD | 0.66% | $28.79M | -13.64% | 0.00% |
ACI | -0.78% | $11.95B | +7.29% | 2.54% |
VSA | -0.80% | $8.67M | -15.70% | 0.00% |
AGL | -0.92% | $956.23M | -64.68% | 0.00% |
MSIF | -0.97% | $769.00M | +36.08% | 6.63% |
OXBR | -1.18% | $13.03M | -26.47% | 0.00% |
CORT | 1.19% | $7.76B | +125.36% | 0.00% |
AMT | 1.21% | $101.95B | +12.04% | 3.05% |
KO | 1.30% | $302.72B | +10.49% | 2.83% |
PSQH | 1.52% | $93.81M | -45.36% | 0.00% |
CME | -1.54% | $99.01B | +39.76% | 3.87% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UTEN | -0.07% | $209.88M | 0.15% |
IEF | -0.14% | $34.98B | 0.15% |
AGZD | 0.18% | $102.66M | 0.23% |
BIL | 0.31% | $42.87B | 0.1356% |
DFNM | -0.33% | $1.56B | 0.17% |
FLGV | -0.35% | $1.01B | 0.09% |
SPSK | -0.49% | $316.15M | 0.5% |
BSV | 0.51% | $38.37B | 0.03% |
WEAT | -0.56% | $117.15M | 0.28% |
TBLL | 0.62% | $2.13B | 0.08% |
CLIP | 0.73% | $1.52B | 0.07% |
IBD | 0.73% | $384.79M | 0.43% |
JPLD | -1.03% | $1.76B | 0.24% |
STIP | 1.04% | $12.71B | 0.03% |
SCHR | -1.19% | $11.12B | 0.03% |
SMB | -1.22% | $274.71M | 0.07% |
IBTM | -1.29% | $316.18M | 0.07% |
GOVZ | 1.41% | $270.29M | 0.1% |
IGOV | 1.52% | $1.21B | 0.35% |
VTIP | -1.58% | $15.34B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -15.99% | $21.70M | -78.27% | 0.00% |
CBOE | -11.59% | $23.98B | +34.66% | 1.10% |
MCK | -8.87% | $90.65B | +24.27% | 0.39% |
VSTA | -5.99% | $342.46M | +40.00% | 0.00% |
PM | -5.94% | $281.78B | +78.65% | 3.00% |
HUSA | -5.78% | $22.94M | -6.82% | 0.00% |
STG | -5.15% | $29.06M | -28.79% | 0.00% |
EXC | -3.74% | $43.32B | +23.98% | 3.65% |
BTCT | -3.60% | $18.98M | +37.85% | 0.00% |
MO | -3.41% | $98.96B | +28.98% | 6.98% |
UUU | -3.26% | $6.64M | +78.38% | 0.00% |
AQB | -3.15% | $2.84M | -54.35% | 0.00% |
AIFU | -2.02% | $6.13B | +82.50% | 0.00% |
K | -1.94% | $27.41B | +36.96% | 2.88% |
DRD | -1.77% | $1.12B | +50.52% | 2.12% |
NEUE | -1.66% | $61.96M | +27.57% | 0.00% |
CME | -1.54% | $99.01B | +39.76% | 3.87% |
OXBR | -1.18% | $13.03M | -26.47% | 0.00% |
MSIF | -0.97% | $769.00M | +36.08% | 6.63% |
AGL | -0.92% | $956.23M | -64.68% | 0.00% |